Chemistry: analytical and immunological testing – Biospecific ligand binding assay – Utilizing isolate of tissue or organ as binding agent
Patent
1994-07-29
1996-06-11
Ceperley, Mary E.
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
Utilizing isolate of tissue or organ as binding agent
436504, 436531, 436541, 436542, 436815, G01N 33538, G01N 33545
Patent
active
055255230
ABSTRACT:
A new homogeneous cytosolic binding protein (FKBP-14.6 immunophilin) having a molecular weight of about 14.6 kDa (calculated from its amino acid composition), reversibly binds the immunosuppressive drugs FK-506, rapamycin or chemically related compounds, but not cyclosporine. The FKBP-14.6 protein has a pI of 6.5-7.5, and the (partial) N-terminal amino acid sequence: NH.sub.2 -Lys-Leu-Pro-Tyr-Glu-Leu-Lys-X-Asn-Val-Lys-Ala-Phe-X-X-Lys-Val- (where X is undefined), and partial internal amino acid sequences -Val-Leu-Asp-Thr-Ala-Tyr-Glu-Tyr-Gly-Ala-Glu-Ala-Leu-Glu-, -Glu-Phe-Thr-Pro-Val-Phe-Gln-Ala-X-Phe- and -Ser-Leu-Val-Pro-Leu-Val-Gly-X-Lys- (where X is undefined). This N-terminal amino acid sequence exhibits no homology to FKBP-12 or membrane-associated FKBP-13. THe FKBP-14.6 is isolated from the cytosol of mammalian tissues, preferably calf thymus, and can be used in diagnostic and purification procedures involving FK-506 and rapamycin-type immunosuppressant drugs.
REFERENCES:
patent: 5047512 (1991-09-01), Handschumacher et al.
patent: 5109112 (1992-04-01), Siekierka et al.
patent: 5196352 (1993-03-01), Siekerka et al.
patent: 5362629 (1994-11-01), Screiber et al.
Siekierka, John et al., "A Cytosolic Binding Protein for the Immunosuppressant FK506 . . . ", Nature, vol. 341, 1989, pp. 755-757.
Jin et al., "Molecular Cloning of a Membrane-Associated Human FK-506- and Rapamycin-Binding Protein, FKBP-13", PNAS USA, 88:6677-81 (1991).
Nielsen, J. B., et al., PNAS USA, 89:7471-75 (1992).
Jin et al., "Molecular Cloning of a 25-kDa High Affinity Rapamycin Binding Protein, FKBP25", J. Biol. Chem., 267:10942-945 (1992).
Galat, A., et al., "A Rapamycin-Selective 25-kDa Immunophilin", Biochemistry, 31:2427-2434 (1992).
Donnelly, J. G., et al., "Purification of a 50- to 58-kDa Immunophilin . . . ", Transplantation Proceedings., 23:2886-89 (1991).
Fretz, H., et al., "Rapamycin and FK506 Binding Proteins (Immunophilins)", J. Am. Chem. Soc., 113:1409-11 (1991).
Yem, A. W., et al., "The Hsp56 Component of Steroid Receptor . . . ", J. Biol. Chem., 267:2868-71 (1992).
Ceperley Mary E.
Children's Research Institute
LandOfFree
Binding method for FK-506- and rapamycin-like drugs with a novel does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding method for FK-506- and rapamycin-like drugs with a novel, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding method for FK-506- and rapamycin-like drugs with a novel will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-351224